NO160262C - Analogifremgangsmaate for fremstilling av epimert azahomoerytromycin a samt mellom-produkt for fremstilling av dette. - Google Patents

Analogifremgangsmaate for fremstilling av epimert azahomoerytromycin a samt mellom-produkt for fremstilling av dette.

Info

Publication number
NO160262C
NO160262C NO834146A NO834146A NO160262C NO 160262 C NO160262 C NO 160262C NO 834146 A NO834146 A NO 834146A NO 834146 A NO834146 A NO 834146A NO 160262 C NO160262 C NO 160262C
Authority
NO
Norway
Prior art keywords
preparation
epimert
azahomoerytromycin
intermediate product
analogue procedure
Prior art date
Application number
NO834146A
Other languages
English (en)
Norwegian (no)
Other versions
NO834146L (no
NO160262B (no
Inventor
Gene Michael Bright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO834146L publication Critical patent/NO834146L/no
Publication of NO160262B publication Critical patent/NO160262B/no
Publication of NO160262C publication Critical patent/NO160262C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Cosmetics (AREA)
NO834146A 1982-11-15 1983-11-14 Analogifremgangsmaate for fremstilling av epimert azahomoerytromycin a samt mellom-produkt for fremstilling av dette. NO160262C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15

Publications (3)

Publication Number Publication Date
NO834146L NO834146L (no) 1984-05-16
NO160262B NO160262B (no) 1988-12-19
NO160262C true NO160262C (no) 1989-03-29

Family

ID=23755068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834146A NO160262C (no) 1982-11-15 1983-11-14 Analogifremgangsmaate for fremstilling av epimert azahomoerytromycin a samt mellom-produkt for fremstilling av dette.

Country Status (26)

Country Link
EP (1) EP0109253B1 (cs)
JP (1) JPS59104398A (cs)
KR (1) KR850000968B1 (cs)
AT (1) ATE30237T1 (cs)
AU (1) AU544790B2 (cs)
CA (1) CA1239639A (cs)
CS (1) CS241069B2 (cs)
DD (1) DD216017A5 (cs)
DE (1) DE3374065D1 (cs)
DK (1) DK159322C (cs)
EG (1) EG16641A (cs)
ES (2) ES8600327A1 (cs)
FI (1) FI72980C (cs)
GR (1) GR79425B (cs)
GT (1) GT198304062A (cs)
HU (1) HU193886B (cs)
IE (1) IE56234B1 (cs)
IL (1) IL70228A (cs)
NO (1) NO160262C (cs)
NZ (1) NZ206259A (cs)
PH (2) PH19293A (cs)
PL (2) PL142601B1 (cs)
PT (1) PT77645B (cs)
SU (1) SU1272996A3 (cs)
YU (2) YU43198B (cs)
ZA (1) ZA838460B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
EP0515141A1 (en) * 1991-05-20 1992-11-25 Merck & Co. Inc. Novel process for the preparation of 8A-aza-8A-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
MX9605419A (es) * 1994-05-06 1997-12-31 Pfizer Formas de dosificacion de liberacion controlada de azitromicina.
CZ290072B6 (cs) * 1995-06-29 2002-05-15 Texas Biotechnology Corporation Di- a trivalentní malé molekuly selektinových inhibitorů
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
MXPA02001897A (es) * 1999-08-24 2002-10-31 Abbott Lab 9a-azalidas con actividad antibacteriana.
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
US6586576B2 (en) * 2000-01-04 2003-07-01 Teva Pharmaceutical Industries Ltd Preparation method of azithromycin hydrates
AU2001280000A1 (en) 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053656A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
SI1691787T1 (sl) 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
HU193886B (en) 1987-12-28
FI72980C (fi) 1987-08-10
YU197285A (en) 1986-08-31
ES527249A0 (es) 1985-10-01
NO834146L (no) 1984-05-16
FI834163L (fi) 1984-05-16
IE56234B1 (en) 1991-05-22
PT77645B (en) 1986-05-12
KR850000968B1 (ko) 1985-07-02
ES8604257A1 (es) 1986-01-16
GR79425B (cs) 1984-10-22
SU1272996A3 (ru) 1986-11-23
IE832652L (en) 1984-05-15
EP0109253A2 (en) 1984-05-23
DK518683A (da) 1984-05-16
ES8600327A1 (es) 1985-10-01
YU43425B (en) 1989-06-30
DK159322B (da) 1990-10-01
IL70228A0 (en) 1984-02-29
PL143281B1 (en) 1988-01-30
ATE30237T1 (de) 1987-10-15
JPH0140038B2 (cs) 1989-08-24
PT77645A (en) 1983-12-01
DK159322C (da) 1991-02-25
PH21560A (en) 1987-12-11
EP0109253A3 (en) 1984-09-12
DD216017A5 (de) 1984-11-28
NZ206259A (en) 1986-08-08
EP0109253B1 (en) 1987-10-14
CS845583A2 (en) 1985-07-16
PL142601B1 (en) 1987-11-30
DE3374065D1 (en) 1987-11-19
ZA838460B (en) 1985-06-26
YU43198B (en) 1989-04-30
CS241069B2 (en) 1986-03-13
EG16641A (en) 1990-08-30
KR840006673A (ko) 1984-12-01
JPS59104398A (ja) 1984-06-16
FI834163A0 (fi) 1983-11-14
YU224383A (en) 1986-04-30
HUT35273A (en) 1985-06-28
PH19293A (en) 1986-03-04
PL250350A1 (en) 1985-04-24
ES543638A0 (es) 1986-01-16
FI72980B (fi) 1987-04-30
PL244557A1 (en) 1985-03-26
AU544790B2 (en) 1985-06-13
CA1239639A (en) 1988-07-26
AU2130983A (en) 1984-05-24
DK518683D0 (da) 1983-11-14
IL70228A (en) 1987-03-31
GT198304062A (es) 1985-05-04
NO160262B (no) 1988-12-19

Similar Documents

Publication Publication Date Title
NO160262C (no) Analogifremgangsmaate for fremstilling av epimert azahomoerytromycin a samt mellom-produkt for fremstilling av dette.
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
FR2361114A1 (fr) Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus
DE3170503D1 (en) 3-0-demethyl derivatives of istamycin b series compounds and their preparation
SE8009049L (sv) 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
PT81118A (en) Process for preparing novel antibiotics and pharmaceutical compositions therefrom
GR76383B (cs)

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN NOVEMBER 2003

MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003